149 related articles for article (PubMed ID: 27118335)
1. [Marked efficacy of adalimumab for secondary gastrointestinal amyloidosis accompanied with ankylosing spondylitis].
Abe T; Azuma N; Kono T; Hao H; Hirota S; Ogita C; Yokoyama Y; Furukawa T; Yoshikawa T; Hino T; Saito A; Nishioka A; Sekiguchi M; Kitano M; Tsunoda S; Matsui K; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(6):473-9. PubMed ID: 27118335
[TBL] [Abstract][Full Text] [Related]
2. The burden of amyloidosis on the gastrointestinal tract of an ankylosing spondylitis patient.
Ozçakar L; Köklü S; Kaymak B; Kuran S; Sakaoğullari Z
Clin Rheumatol; 2003 Dec; 22(6):440-2. PubMed ID: 14677023
[TBL] [Abstract][Full Text] [Related]
3. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N
Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
[TBL] [Abstract][Full Text] [Related]
4. Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
Immonen K; Kauppi M; Hakala M
Scand J Rheumatol; 2011 May; 40(3):236-8. PubMed ID: 21231814
[No Abstract] [Full Text] [Related]
5. Improvement of endoscopic and histologic findings of AA-type gastrointestinal amyloidosis by treatment with dimethyl sulfoxide and prednisolone.
Takahashi A; Matsumoto J; Nishimura S; Tanida N; Imura S; Isobe T; Shimoyama T
Gastroenterol Jpn; 1985 Apr; 20(2):143-7. PubMed ID: 4029551
[TBL] [Abstract][Full Text] [Related]
6. [The possibilities of using colchicine in rheumatoid arthritis and amyloidosis].
Chegaeva TV; Vinogradova OM; Kochubeĭ LN
Ter Arkh; 1990; 62(5):120-4. PubMed ID: 2396209
[No Abstract] [Full Text] [Related]
7. The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up.
Yilmaz H; Kocabas H; Erkin G
Acta Reumatol Port; 2013; 38(4):299-301. PubMed ID: 24435036
[TBL] [Abstract][Full Text] [Related]
8. [Nephrotic syndrome and amyloidosis in chronic rheumatic processes].
Schilling A
Med Klin; 1969 Mar; 64(10):425-9. PubMed ID: 5771968
[No Abstract] [Full Text] [Related]
9. Long-term follow-up of systemic reactive AA amyloidosis secondary to rheumatoid arthritis: successful treatment with intermediate-dose corticosteroid.
Matsuda M; Morita H; Ikeda S
Intern Med; 2002 May; 41(5):403-7. PubMed ID: 12058893
[TBL] [Abstract][Full Text] [Related]
10. Secondary amyloidosis: a severe complication of ankylosing spondylitis. Two case-reports.
Kovacsovics-Bankowski M; Zufferey P; So AK; Gerster JC
Joint Bone Spine; 2000; 67(2):129-33. PubMed ID: 10769106
[TBL] [Abstract][Full Text] [Related]
11. Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis.
McMahan ZH; Sailors JL; Toto R; Olsen NJ
J Clin Rheumatol; 2010 Jan; 16(1):22-5. PubMed ID: 20051751
[TBL] [Abstract][Full Text] [Related]
12. Successful adalimumab treatment and usefulness of capsule endoscopy for gut inflammation concomitant with ankylosing spondylitis.
Ota S; Sakuraba H; Hiraga H; Hasui K; Satake M; Hanabata N; Akemoto Y; Watanabe R; Tanaka N; Ishiguro Y; Tanaka M; Fukuda S
Mod Rheumatol; 2019 Jul; 29(4):708-713. PubMed ID: 28271948
[TBL] [Abstract][Full Text] [Related]
13. A case report of severe recurrent varicella in an ankylosing spondylitis patient treated with adalimumab - a new side effect after 15 years of usage.
Skuhala T; Atelj A; Prepolec J; Al-Mufleh M; Stanimirović A; Vukelić D
BMC Infect Dis; 2019 Feb; 19(1):127. PubMed ID: 30732563
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Yamamura Y; Tomoda K; Tsukano M; Shono M; Baba S
Clin Rheumatol; 2003 Dec; 22(6):371-5. PubMed ID: 14677008
[TBL] [Abstract][Full Text] [Related]
15. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
[TBL] [Abstract][Full Text] [Related]
16. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
[TBL] [Abstract][Full Text] [Related]
17. [Ankylosing spondylitis and amyloidosis. Apropos of 2 cases].
Hajjaj-Hassouni N; Laghrissi S; Khalil A; Mkinsi O; Maaouni A; Berbich A; Tazi A
Rev Rhum Mal Osteoartic; 1982 Oct; 49(10):687-91. PubMed ID: 7156822
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis.
Jeong YS; Jun JB; Kim TH; Lee IH; Bae SC; Yoo DH; Park MH; Kim SY
Clin Exp Rheumatol; 2000; 18(5):619-21. PubMed ID: 11072606
[TBL] [Abstract][Full Text] [Related]
19. An examination of the mechanisms involved in secondary clinical failure to adalimumab or etanercept in inflammatory arthropathies.
Bandrés Ciga S; Salvatierra J; López-Sidro M; García-Sánchez A; Durán R; Vives F; Raya-Álvarez E
J Clin Rheumatol; 2015 Apr; 21(3):115-9. PubMed ID: 25807089
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S
Clin Exp Rheumatol; 2007; 25(4):518-22. PubMed ID: 17888205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]